Jin‐Liern Hong
-
- Cancer Risks and Factors 3
- Colorectal Cancer Treatments and Studies 3
- Statistics and Probability top 10%
-
- Diabetes Treatment and Management 3
-
- Cancer Genomics and Diagnostics 3
- Carcinogens and Genotoxicity Assessment 2
-
- Lung Cancer Treatments and Mutations 7
-
- Metabolism, Diabetes, and Cancer 3
- Genomics, phytochemicals, and oxidative stress 2
- Co-authors
- Ah‐Ng Tony KongSandhya MandlekarTil StürmerMichele Jönsson FunkSai‐Hong Ignatius OuJohn B. BuseHuamao Mark LinVirginia Pate
- Partner nations
- United StatesTaiwanUnited Kingdom
In The Last Decade
Jin‐Liern Hong
25 papers receiving 389 citations
Peers
Comparison fields: 5 of 84
- Oncology 124
- Pharmacology 37
- Statistics and Probability 32
- Endocrinology, Diabetes and Metabolism 65
- Cancer Research 41
Countries citing papers authored by Jin‐Liern Hong
This map shows the geographic impact of Jin‐Liern Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin‐Liern Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin‐Liern Hong more than expected).
Fields of papers citing papers by Jin‐Liern Hong
This network shows the impact of papers produced by Jin‐Liern Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin‐Liern Hong. The network helps show where Jin‐Liern Hong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jin‐Liern Hong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 25 | |
| 6 | 2023 | 27 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 20 | |
| 10 | 2018 | 14 | |
| 11 | 2017 | 20 | |
| 12 | 2017 | 17 | |
| 13 | 2017 | 2 | |
| 14 | 2017 | 26 | |
| 15 | 2016 | 10 | |
| 16 | 2015 | 29 | |
| 17 | 2014 | 32 | |
| 18 | 2010 | 16 | |
| 19 | 2007 | 7 | |
| 20 | 2006 | 56 |
About Jin‐Liern Hong
Jin‐Liern Hong is a scholar working on Cancer Research, Oncology and Pharmacology, having authored 26 papers that have together received 394 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer Risks and Factors (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Diabetes Treatment and Management (3 papers), Cancer Genomics and Diagnostics (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). The work is most often cited by research in Oncology (124 citations), Pharmacology (37 citations) and Statistics and Probability (32 citations). Jin‐Liern Hong has collaborated with scholars based in United States, Taiwan and United Kingdom. Frequent co-authors include Ah‐Ng Tony Kong, Sandhya Mandlekar, Til Stürmer, Michele Jönsson Funk, Sai‐Hong Ignatius Ou, John B. Buse, Huamao Mark Lin, Virginia Pate, Shu Jin and Danny Nguyen. Their work appears in journals such as Journal of Clinical Oncology, Blood and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.